Search research articles
Contact Us
Filters
Showing results (1-10 of 203) with videos related to
Page
of 21
Sort By:
Research and Practice in Thrombosis and Haemostasis
|
March 1, 2024
Accumulating evidence for direct oral anticoagulants in liver disease
Karina Meijer
Seminars in Thrombosis and Hemostasis
|
February 14, 2009
Determinants of bleeding risk in patients on antithrombotic and antifibrinolytic drugs
Karina Meijer, Sam Schulman
Thrombosis Research
|
May 31, 2015
Determinants and consequences of differences in quality of anticoagulation therapy with vitamin K antagonists
Vladimir Tichelaar, Karina Meijer
Journal of Thrombosis and Haemostasis : JTH
|
June 30, 2024
Time to simplify perioperative management of vitamin K antagonists
Karina Meijer, Daniel M Witt
Nederlands Tijdschrift Voor Geneeskunde
|
April 1, 2021
[Tranexamic acid: widely applicable, few risks]
Marjet A Stein-Wit, Karina Meijer
International Journal of Laboratory Hematology
|
November 21, 2020
Genetic testing of hereditary antithrombin deficiency in a large US pedigree using saliva samples
René Mulder, Karina Meijer, Michaël V Lukens
Pharmacoepidemiology and Drug Safety
|
February 6, 2018
Re: Quality of warfarin therapy and risk of stroke, bleeding, and mortality among patients with atrial fibrillation
Jasper H A van Miert, Karina Meijer
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 6, 2022
Diagnosis of rare bleeding disorders
Karina Meijer, Waander van Heerde, Keith Gomez
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 25, 2020
Diagnosis of rare bleeding disorders
Karina Meijer, Waander van Heerde, Keith Gomez
Research and Practice in Thrombosis and Haemostasis
|
October 11, 2024
Can hemophilia be cured? It depends on the definition
Lieke Baas, Rieke van der Graaf, Karina Meijer
Page
of 21
Search research articles
Search
Showing results (1-10 of 203) with videos related to
Sort By:
Page
of 21
Research and Practice in Thrombosis and Haemostasis
|
March 1, 2024
Accumulating evidence for direct oral anticoagulants in liver disease
Karina Meijer
Seminars in Thrombosis and Hemostasis
|
February 14, 2009
Determinants of bleeding risk in patients on antithrombotic and antifibrinolytic drugs
Karina Meijer, Sam Schulman
Thrombosis Research
|
May 31, 2015
Determinants and consequences of differences in quality of anticoagulation therapy with vitamin K antagonists
Vladimir Tichelaar, Karina Meijer
Journal of Thrombosis and Haemostasis : JTH
|
June 30, 2024
Time to simplify perioperative management of vitamin K antagonists
Karina Meijer, Daniel M Witt
Nederlands Tijdschrift Voor Geneeskunde
|
April 1, 2021
[Tranexamic acid: widely applicable, few risks]
Marjet A Stein-Wit, Karina Meijer
International Journal of Laboratory Hematology
|
November 21, 2020
Genetic testing of hereditary antithrombin deficiency in a large US pedigree using saliva samples
René Mulder, Karina Meijer, Michaël V Lukens
Pharmacoepidemiology and Drug Safety
|
February 6, 2018
Re: Quality of warfarin therapy and risk of stroke, bleeding, and mortality among patients with atrial fibrillation
Jasper H A van Miert, Karina Meijer
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 6, 2022
Diagnosis of rare bleeding disorders
Karina Meijer, Waander van Heerde, Keith Gomez
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 25, 2020
Diagnosis of rare bleeding disorders
Karina Meijer, Waander van Heerde, Keith Gomez
Research and Practice in Thrombosis and Haemostasis
|
October 11, 2024
Can hemophilia be cured? It depends on the definition
Lieke Baas, Rieke van der Graaf, Karina Meijer
Page
of 21